Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Contact information


angela.minassian@paediatrics.ox.ac.uk

Social media

Angela Minassian

MA (Cantab), MRCP, DPhil, FRCPath

Associate Professor

  • Chief Investigator Malaria Vaccine Clinical Trials
  • Research Fellow Wolfson College
  • Honorary Consultant in Infectious Diseases (Oxford University Hospitals NHS Foundation Trust)
  • Vice-Chair Graduate Studies Committee (Medical Sciences Division)

I am an infectious diseases physician by training and lead a clinical malaria vaccine programme at the University of Oxford. This involves testing first-time-in-human vaccines against Plasmodium falciparum and Plasmodium vivax, incorporating controlled human malaria infection to test vaccine efficacy.

I am passionate about building relationships and transferring skills to empower the research teams where malaria is endemic, and our trials now span Phase 1/2 in the UK and across East and West Africa. I also currently co-lead the EDCTP3-funded 2nd-Generation Malaria Vaccine Consortium (MVC-2G).

Using the platform of the malaria human challenge model I also conduct experimental medicine research to explore mechanisms of disease tolerance, and am developing a novel model of relapse for Plasmodium vivax. I have also run clinical trials of vaccines against emerging pathogens and have an interest in developing new human challenge models of infection with which to assess new vaccines.